Covid Testing Company LumiraDx Goes Public in SPAC

The CEO of Lumira DX discusses the company's role in COVID testing and its broader platform for community care. Lumira DX aims to transform healthcare with high-performance tests for various diseases. The company has major clients like CVS and the NHS and plans to expand its product range and global capacity using funds from a recent deal. Despite the pandemic's end, COVID-related testing will continue, alongside innovations in other health areas.

What is the primary purpose of Lumira DX's platform in community care?

How has Lumira DX adapted its services in response to the COVID-19 pandemic?

What types of diseases does Lumira DX aim to address with its platform?

What are some of the expected benefits of the new tests being developed by Lumira DX?

What plans does Lumira DX have for expanding its capacity in the future?